Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response

Ann Rheum Dis. 2021 Oct;80(10):1361-1362. doi: 10.1136/annrheumdis-2021-220834. Epub 2021 Jun 24.
No abstract available

Keywords: COVID-19; Methotrexate; Rheumatoid Arthritis; Vaccination.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Neutralizing / blood
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / immunology*
  • BNT162 Vaccine
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / immunology*
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Immunization, Secondary
  • Immunocompromised Host / immunology*
  • Immunogenicity, Vaccine / drug effects
  • Immunogenicity, Vaccine / immunology
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Polycythemia Vera / complications
  • SARS-CoV-2
  • Vasculitis, Leukocytoclastic, Cutaneous / complications

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antirheumatic Agents
  • COVID-19 Vaccines
  • Heterocyclic Compounds, 3-Ring
  • upadacitinib
  • BNT162 Vaccine
  • Methotrexate

Supplementary concepts

  • COVID-19 vaccine booster shot